Raymond Finn, MD
Gastroenterology · Nashville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Vanderbilt University Medical Center · 3,510 clinicians in this group
Hospitals listed: Vanderbilt University Medical Center · Williamson Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Finn’s office at (615) 322-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A162924 · Cancelled
Licence status: Cancelled · since 2019 · Geisel School of Medicine at Dartmouth.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Tennessee 63801Medical Doctor · since 2021 · expires 2028-05-31Specialty on the licence: GastroenterologyLicensedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Dartmouth Medical School · MDHANOVER, NH · 2012Medical school
Residency and fellowship
- Fellowship, Gastroenterology and HepatologyDurham, NC · 2016–2019
- Internship and Residency, Internal MedicineBoston, MA · 2012–2015
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vanderbilt University Medical CenterNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Vanderbilt Health, which runs 4 hospitalsHome of Vanderbilt-Ingram Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.28 (2.41 to 4.15) · 6,585 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.2 (0.85 to 1.54) · 15,700 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.591, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.703, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,175 cases, Jan 2024 – Dec 2024
- Williamson Medical CenterFranklin, TNAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Williamson County Hospital DistrictPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.142, Oct 2024 – Sep 2025
See every measure and the patient survey for Vanderbilt University Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (2.41 to 4.15) · 6,585 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.2 (0.85 to 1.54) · 15,700 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,175 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.56 to 1.87) · 4,737 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.97 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.72 (117.43 to 174.02) · 459 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 632 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 466 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 557 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 7,242 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.14 to 0.46) · 17,585 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.05 to 0.37) · 18,947 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.16 (1.96 to 4.35) · 7,265 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.44 to 2.22) · 4,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (6.38 to 11.73) · 4,115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.74 (3.02 to 6.45) · 4,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.48 to 2.84) · 1,745 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 156 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.072 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.406 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.337 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 400 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 288 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.6 · 752 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.7 · 504 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 668 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.2 to 6.4) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (9.9 to 13) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.9 (8.8 to 13.5) · 4,301 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,643 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Williamson Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.142 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.13 to 2.14) · 865 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.57 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.8 (138.58 to 265.02) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 401 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 444 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 2,545 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.06 to 0.48) · 5,270 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 5,075 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.24 (0.13 to 4.36) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.49 (0 to 3.12) · 719 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.61 (1.08 to 4.15) · 1,372 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.78 (3.63 to 17.94) · 728 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.1 (0.26 to 7.94) · 676 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.15) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0 to 1.38) · 3,131 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6 · 72 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.726 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.62 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.776 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.715 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 144 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 604 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -35.9 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.1 · 467 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -34.3 · 481 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 571 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 62 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.8 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.4 to 15.9) · 1,358 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.4) · 997 cases | No different | Jan 2024 – Dec 2024 |
What patients said (734 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$79,048
Medicare paid this office $79,048 for 456 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 179 | $35,838 | $199 |
| Return visit (30+ min) | 97 | $10,078 | $89 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $6,652 | $175 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $5,835 | $172 |
| New patient visit (45+ min) | 50 | $5,508 | $110 |
See all 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 179 | $35,838 | $199 |
| Return visit (30+ min) | 97 | $10,078 | $89 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $6,652 | $175 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $5,835 | $172 |
| New patient visit (45+ min) | 50 | $5,508 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $3,133 | $55 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,405 | $134 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 19 | $1,630 | $86 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 20 | $1,603 | $80 |
| Biopsy of large bowel using a flexible endoscope | 15 | $1,590 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,219 | $102 |
| Short return visit (20+ min) | 19 | $1,139 | $57 |
Procedures Medicare counted
| Colonoscopy | 224 | More than 95% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 122 | More than 81% of doctors who do this |
Who their Medicare patients are
456 Original Medicare patients in 2024. Average age 73 · Under 65 4% · 85 and older 4% · Women 57% · Health risk score 0.90. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 66% · Coronary heart disease 23% · Diabetes 22% · Depression 20% · Cancer 19% · Chronic kidney disease 15% · Atrial fibrillation 14% · Heart failure 11% · COPD 9% · Stroke 5% · Dementia 4%.
The office billed $560,746, Medicare allowed $95,619 and paid $79,048; for 613 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 456 | 613 | 73 | 0.90 | $560,746 | $79,048 |
| 2023 | 446 | 667 | 73 | 0.89 | $605,718 | $81,502 |
| 2022 | 411 | 627 | 73 | 0.89 | $490,094 | $72,964 |
| 2021 | 125 | 228 | 73 | 1.04 | $163,122 | $23,830 |
| 2020 | 166 | 394 | 74 | 1.10 | $319,357 | $42,670 |
| 2019 | 49 | 89 | 72 | 0.98 | $74,118 | $10,245 |
| 2016 | 45 | 45 | 69 | 3.20 | $22,695 | $4,710 |
| 2015 | 43 | 44 | 69 | 2.58 | $21,181 | $4,829 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 188 | $35,895 | $190 |
| Return visit (30+ min) | 108 | $11,752 | $86 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 41 | $6,602 | $161 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $5,522 | $162 |
| New patient visit (45+ min) | 39 | $4,150 | $106 |
| Biopsy of large bowel using a flexible endoscope | 29 | $3,272 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $2,414 | $59 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 26 | $2,092 | $80 |
| Short return visit (20+ min) | 29 | $2,056 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,028 | $97 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $932 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $514 | $37 |
2022: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 145 | $27,454 | $188 |
| Return visit (30+ min) | 95 | $11,471 | $90 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 37 | $6,428 | $174 |
| New patient visit (45+ min) | 41 | $4,557 | $111 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $3,641 | $173 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $3,193 | $59 |
| Biopsy of large bowel using a flexible endoscope | 33 | $3,169 | $96 |
| Short return visit (20+ min) | 47 | $2,879 | $56 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $1,736 | $124 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 14 | $1,568 | $112 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 14 | $1,432 | $102 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,292 | $76 |
2021: 6 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,809 | $232 |
| Short return visit (20+ min) | 41 | $4,674 | $77 |
| New patient visit (45+ min) | 23 | $2,760 | $120 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,701 | $90 |
| Return visit (30+ min) | 13 | $1,464 | $105 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 38 | $200 | $5 |
2020: 8 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 55 | $12,822 | $229 |
| New patient visit (45+ min) | 46 | $6,921 | $150 |
| Return visit (30+ min) | 34 | $5,302 | $102 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,032 | $217 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,553 | $91 |
| Short return visit (20+ min) | 26 | $2,049 | $68 |
| Biopsy of large bowel using a flexible endoscope | 17 | $1,461 | $86 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 86 | $452 | $5 |
2019: 3 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,567 | $233 |
| New patient visit (45+ min) | 14 | $2,139 | $153 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $90 | $5 |
2016: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,544 | $106 |
2015: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,626 | $113 |
Drugs they prescribed that Part D paid
$473,725
Pharmacies billed $473,725 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 766) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
603 generic and 163 brand-name prescriptions · $473,725 in drug cost · 20 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 18 | $122,820 | $6,823 |
| Linzess | 43 | $47,869 | $1,113 |
| Trulance | 11 | $12,440 | $1,131 |
| Mesalamine | 23 | $9,002 | $391 |
| Movantik | 11 | $5,381 | $489 |
See all 17 drugs
| Humira(Cf) | 18 | $122,820 | $6,823 |
| Linzess | 43 | $47,869 | $1,113 |
| Trulance | 11 | $12,440 | $1,131 |
| Mesalamine | 23 | $9,002 | $391 |
| Movantik | 11 | $5,381 | $489 |
| Esomeprazole Magnesium | 70 | $3,345 | $48 |
| Omeprazole | 188 | $2,478 | $13 |
| Budesonide Dr | 21 | $2,405 | $115 |
| Sucralfate | 21 | $2,186 | $104 |
| Pantoprazole | 123 | $1,624 | $13 |
| Mercaptopurine | 15 | $1,390 | $93 |
| Cholestyramine | 13 | $937 | $72 |
| Sulfasalazine | 16 | $704 | $44 |
| Lansoprazole | 13 | $509 | $39 |
| Dicyclomine | 20 | $397 | $20 |
| Ondansetron Odt | 14 | $391 | $28 |
| Famotidine | 19 | $229 | $12 |
Year by year
| 2024 | 766 | 235 | 0% (0) | 21% | $473,725 |
| 2023 | 623 | 209 | None | 25% | $417,703 |
| 2022 | 515 | 172 | 0% (0) | 26% | $379,577 |
| 2021 | 160 | 66 | 0% (0) | 28% | $101,924 |
| 2020 | 197 | 112 | 0% (0) | 36% | $16,224 |
| 2019 | 42 | 36 | 0% (0) | 31% | $2,637 |
| 2017 | 41 | None | 0% (0) | 27% | $36,030 |
| 2016 | 15 | None | 0% (0) | None | $162,070 |
| 2015 | 24 | None | 0% (0) | None | $2,822 |
| 2014 | 56 | 12 | None | None | $4,174 |
| 2013 | 79 | 15 | 0% (0) | None | $12,825 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Humira(Cf) | 14 | $104,843 | $7,489 |
| Linzess | 39 | $42,899 | $1,100 |
| Mesalamine | 26 | $14,547 | $559 |
| Budesonide Dr | 19 | $3,717 | $196 |
| Omeprazole | 147 | $2,821 | $19 |
| Mercaptopurine | 14 | $2,676 | $191 |
| Pantoprazole | 111 | $2,048 | $18 |
| Loperamide | 11 | $1,622 | $147 |
| Cholestyramine | 19 | $1,413 | $74 |
| Sulfasalazine | 15 | $943 | $63 |
| Sucralfate | 11 | $626 | $57 |
| Esomeprazole Magnesium | 17 | $565 | $33 |
| Dicyclomine | 12 | $374 | $31 |
| Lansoprazole | 12 | $369 | $31 |
| Famotidine | 13 | $132 | $10 |
2022: 13 drugs
| Humira(Cf) | 20 | $138,199 | $6,910 |
| Viberzi | 11 | $16,902 | $1,537 |
| Linzess | 18 | $16,885 | $938 |
| Mesalamine | 14 | $6,282 | $449 |
| Budesonide Dr | 18 | $2,478 | $138 |
| Mercaptopurine | 18 | $2,472 | $137 |
| Pantoprazole | 96 | $1,740 | $18 |
| Omeprazole | 87 | $1,678 | $19 |
| Esomeprazole Magnesium | 15 | $849 | $57 |
| Sulfasalazine | 13 | $808 | $62 |
| Lansoprazole | 20 | $532 | $27 |
| Dicyclomine | 28 | $468 | $17 |
| Famotidine | 16 | $342 | $21 |
2021: 4 drugs
| Suprep | 16 | $1,778 | $111 |
| Esomeprazole Magnesium | 11 | $1,185 | $108 |
| Omeprazole | 45 | $1,089 | $24 |
| Pantoprazole | 15 | $204 | $14 |
2020: 5 drugs
| Suprep | 38 | $3,960 | $104 |
| Omeprazole | 50 | $1,369 | $27 |
| Peg 3350-Electrolyte | 20 | $280 | $14 |
| Gavilyte-N | 14 | $192 | $14 |
| Pantoprazole | 11 | $117 | $11 |
2019: 1 drug
| Gavilyte-C | 11 | $129 | $12 |
2017: 1 drug
| Omeprazole | 11 | $79 | $7 |
2013: 1 drug
| Metoprolol | 11 | $653 | $59 |
Money from drug and device companies
$128 in 2025
| 2025 | 1 | 1 | None | $128 |
| 2022 | 2 | 2 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ardelyx | Ibsrela | $128 | 1 payment
|
See the published payment
| Ardelyx | Meals · 2025-04-02 | Ibsrela | $128 |
See earlier years (2022)
2022: $41
| Genzyme | Dupixent | $22 | 1 payment
|
| RedHill Biopharma | Talicia | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699038869
- Licence
- CA A162924, MA 251530, TN 63801California A162924: CancelledTennessee 63801: Licensed
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 3841 Green Hills Village Dr Ste 200, Nashville, TN, 37215
- NPI first listed
- 2012-06-21
- NPI last updated
- 2022-03-25
- NPI record certified
- 2022-03-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 701 E El Camino Real, Mountain View, CA, 94040
This office lists an electronic records connection.